The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -12,893,602 | -83,618,591 |
| Depreciation and amortization | 975,275 | - |
| Loss on disposal of property and equipment | 0 | 0 |
| Non cash interest income on note receivable | 825,346 | 363,798 |
| Stock-based compensation | 4,483,808 | 6,319,378 |
| Convertible note payable for non-cash issuance costs | 0 | 0 |
| Shares issued for non-cash consultant expense | 0 | 673,497 |
| Change in fair value of share liability | -70,869 | -129,269 |
| Change in fair value of convertible notes payable | 172,836 | -64,715,131 |
| Change in right-of-use lease asset | 182,501 | 267,952 |
| Depreciation | - | 678,959 |
| Non-cash lease income | 22,476 | 22,064 |
| Change in deferred taxes | 32,890 | 285 |
| Accounts receivable | -1,014,945 | -89,048 |
| Receivable from noncontrolling interest | -353 | -28,353 |
| Inventories | -249,293 | 946,052 |
| Prepaid expenses and other current assets | 2,508,539 | -1,318,444 |
| Other noncurrent assets | -1,082,891 | -103,204 |
| Accounts payable | -1,069,245 | 1,106,878 |
| Accrued expenses | 1,395,595 | -507,883 |
| Operating lease liabilities | -172,706 | -275,614 |
| Other current liabilities | -2,358 | -767,707 |
| Net cash used in operating activities | -8,857,647 | -11,071,311 |
| Purchases of property and equipment | 3,148,212 | 4,107,564 |
| Purchase of equity investments | 5,000,000 | - |
| Cash received for acquisition of business, net of cash paid | -6,643,797 | - |
| Cash advance in exchanges for note receivable | 0 | 30,000,000 |
| Net cash used in investing activities | -1,504,415 | -34,107,564 |
| Payment of notes payable | - | 409,696 |
| Proceeds from bank loans | - | 47,045 |
| Proceeds from issuance of common stock | 60,000,000 | 50,000,000 |
| Payment of principal portion of bank loans | - | 392,263 |
| Payment of common stock issuance costs | 3,693,950 | 3,238,630 |
| Proceeds from exercise of warrants | 0 | 4,915,312 |
| Due to related parties | 590,195 | - |
| Proceeds from noncontrolling interest in vie | 0 | 0 |
| Proceeds from collection of receivable from noncontrolling interest in vie | 0 | 0 |
| Distribution to noncontrolling interest in vie | 324,271 | 79,310 |
| Proceeds from issuance of convertible notes payable | 0 | 0 |
| Proceeds from issuance of debt | 2,804,466 | - |
| Payment of principal portion of debt | 3,384,553 | - |
| Payment of principal portion of finance leases | 42,616 | 61,831 |
| Net cash provided by financing activities | 56,704,185 | 50,780,627 |
| Net change in cash and cash equivalents | 46,342,123 | 5,601,752 |
| Effect of exchange rate changes on cash | 108,233 | - |
| Cash and cash equivalents at beginning of period | 61,890,048 | - |
| Cash and cash equivalents at end of period | 113,942,156 | - |
ASP Isotopes Inc. (ASPI)
ASP Isotopes Inc. (ASPI)